Skip to content

Culture System for Isolating Circulating Tumor cells_2

Culture System for Isolating Circulating Tumor Cells

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04125667
Enrollment
45
Registered
2019-10-14
Start date
2019-10-31
Completion date
2020-08-31
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnostic Techniques and Procedures, Early Diagnosis

Keywords

Circulating cancer cells, Biomedical polymer material, Cell affinity difference, White blood cell attachment

Brief summary

This culture system utilizes the special affinity difference of biomedical material coating for different cells to achieve the effect of isolating tumor cells from the blood sample. The coating of the system has the characteristic that to make the WBCs adhesion, but the cancer cells in the blood sample suspend in the culture medium, which achieves the effect of separating cancer cells from the blood. The supernatant with the cancer cells can further be isolated from the cultural system for related analysis and detection to achieve early diagnosis and screening.

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients with lung cancer are between the ages of 20 and 70 * Willing to sign the consent form under the informed consent

Exclusion criteria

* Vulnerable Subjects included minors, prisoners, aborigines, pregnant women, people with mental disorders, students, and subordinates, etc.

Design outcomes

Primary

MeasureTime frameDescription
The Number of Circulating Cancer Cells from The Blood Sampleabout 1 weekThe number of circulating cancer cells from the blood sample will be investigated. To distinguish cancer cells from blood cells for the system, the lung cancer cells were immunofluorescence stained for Cytokeratin, white blood cells were stained for CD45 and nuclei were counterstained with DAPI.

Secondary

MeasureTime frameDescription
Cancer Cell Isolation Efficiency of The Isolation Systemabout 1 weekThe cell isolation efficiency was characterized by spiking A549 lung cancer cells with celltracker at the concentrations 1000, 100 and 10 cells into whole blood.

Countries

Taiwan

Contacts

Primary ContactTai-Horng Young
thyoung@ntu.edu.tw886-2-23123456
Backup ContactYin-Tzu Chen
R07528032@ntu.edu.tw886-2-23123456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026